Trial intelligence / Profile preview

Remimazolam vs Propofol for Anesthesia During Major Hepatectomy

NCT07789275Phase 4Recruiting

Sponsor
Beijing Tsinghua Changgung Hospital
Start
Sep 2026
Primary completion
Jul 2027
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of remimazolam in intraoperative hypotension (IOH) (2 arms), sponsored by Beijing Tsinghua Changgung Hospital. Primary endpoint: Time-weighted average of mean arterial pressure below 65 mmHg during liver parenchymal transection. Started Sep 2026; status: recruiting.

02

Drugs

remimazolam
03

Conditions

intraoperative hypotension (IOH)

Beyond the preview

Go deeper on NCT07789275.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07789275.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call